加快推動湖湘中醫藥走向世界 湖南開展中醫藥“海外傳播”行動
時間:2020-09-27 14:14:54 閱讀:3027 整理:長沙市場調查公司
近日,省(sheng)衛生健康委、省(sheng)中醫(yi)(yi)(yi)藥(yao)局、省(sheng)委外(wai)(wai)事辦、省(sheng)人力資(zi)源社會保障廳、省(sheng)商(shang)務廳、省(sheng)藥(yao)品(pin)監(jian)管局、省(sheng)僑聯聯合發布《湖(hu)南省(sheng)中醫(yi)(yi)(yi)藥(yao)“海(hai)外(wai)(wai)傳(chuan)播(bo)”行動實施方案(2021-2025年(nian))》(以下簡稱方案),中醫(yi)(yi)(yi)藥(yao)“海(hai)外(wai)(wai)傳(chuan)播(bo)”行動正式啟動。
方案提出,到2025年(nian),湖南擬創建2-3家(jia)海外中(zhong)(zhong)(zhong)(zhong)醫藥(yao)中(zhong)(zhong)(zhong)(zhong)心(xin)、6-8個(ge)(ge)海外中(zhong)(zhong)(zhong)(zhong)醫醫療保健機構、1個(ge)(ge)國(guo)內中(zhong)(zhong)(zhong)(zhong)醫藥(yao)國(guo)際(ji)合作(zuo)基(ji)(ji)地(di)、1家(jia)國(guo)家(jia)級中(zhong)(zhong)(zhong)(zhong)醫藥(yao)服務(wu)出口基(ji)(ji)地(di),5-7個(ge)(ge)中(zhong)(zhong)(zhong)(zhong)藥(yao)產品在海外注冊上市,中(zhong)(zhong)(zhong)(zhong)醫藥(yao)對外貿易(yi)額達400億元。
方(fang)案明確了七項(xiang)重點任(ren)務,分別是健全完善海(hai)(hai)外中(zhong)(zhong)醫(yi)(yi)藥(yao)合(he)作(zuo)機制、實(shi)(shi)施(shi)中(zhong)(zhong)醫(yi)(yi)藥(yao)中(zhong)(zhong)非援助項(xiang)目、實(shi)(shi)施(shi)海(hai)(hai)外中(zhong)(zhong)醫(yi)(yi)藥(yao)醫(yi)(yi)療(liao)服務項(xiang)目、實(shi)(shi)施(shi)海(hai)(hai)外中(zhong)(zhong)醫(yi)(yi)藥(yao)學術合(he)作(zuo)項(xiang)目、實(shi)(shi)施(shi)海(hai)(hai)外中(zhong)(zhong)醫(yi)(yi)藥(yao)文化傳播項(xiang)目、實(shi)(shi)施(shi)中(zhong)(zhong)醫(yi)(yi)藥(yao)對外貿易項(xiang)目、實(shi)(shi)施(shi)海(hai)(hai)外中(zhong)(zhong)醫(yi)(yi)藥(yao)人才培養(yang)項(xiang)目。
其中(zhong)(zhong),方案指出實(shi)(shi)施中(zhong)(zhong)醫藥中(zhong)(zhong)非(fei)援助(zhu)項(xiang)目,要夯實(shi)(shi)援非(fei)中(zhong)(zhong)醫藥服務平臺(tai),加強中(zhong)(zhong)國(guo)(guo)-津巴布韋(wei)中(zhong)(zhong)醫藥中(zhong)(zhong)心等中(zhong)(zhong)醫醫療機(ji)構建設,充(chong)分利用“中(zhong)(zhong)非(fei)經貿(mao)博覽會”平臺(tai)和(he)中(zhong)(zhong)國(guo)(guo)(湖南)自由貿(mao)易試驗區(qu)(qu)優勢(shi),推動更多“湘(xiang)產”中(zhong)(zhong)成藥在非(fei)洲國(guo)(guo)家和(he)地區(qu)(qu)注冊上市,提升湖湘(xiang)中(zhong)(zhong)醫藥海外影響力(li)。
實(shi)施海外中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)醫療(liao)服(fu)務項目,要辦好(hao)湖南中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)大學第一附屬(shu)醫院(yuan)集(ji)團迪拜醫院(yuan)、中(zhong)(zhong)(zhong)(zhong)(zhong)國-巴基斯坦中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)中(zhong)(zhong)(zhong)(zhong)(zhong)心、中(zhong)(zhong)(zhong)(zhong)(zhong)國-德國中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)中(zhong)(zhong)(zhong)(zhong)(zhong)心、中(zhong)(zhong)(zhong)(zhong)(zhong)國-柬(jian)埔寨中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)中(zhong)(zhong)(zhong)(zhong)(zhong)心等海外中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)機構(gou),結合(he)(he)不同(tong)國家(jia)的(de)常見病、多(duo)發(fa)病、慢(man)性(xing)病,創新傳(chuan)統醫學和現代醫學相(xiang)結合(he)(he)的(de)診療(liao)模式,提供中(zhong)(zhong)(zhong)(zhong)(zhong)醫醫療(liao)和養生(sheng)保健服(fu)務,推動中(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)融入相(xiang)關國家(jia)衛生(sheng)和醫療(liao)保障體系。
關注公眾號:
華夏經緯數據科技
更多調研資訊>>
本站文章內容以及所涉數據、圖片等資料來源于網絡,轉載目的在于傳遞更多信息。版權歸作者所有,文章僅代表作者觀點,不代表華夏經緯立場。 如涉及侵權,請聯系管理員刪除。在法律許可的范圍內,華夏經緯(廣州)數據科技股份有限公司享有最終解釋權。